by in
Entry Author Date Location
San Diego Life Sciences Roundup: Tandem Diabetes, Ligand, and More 10/10/13 San Diego
Biogen Idec’s ALS Drug Fails Phase III Trial 01/03/13 Boston
Tantalizing Hints of Progress Against ALS for Cytokinetics, Others 11/14/12 San Francisco
Xconomist of the Week: Tom Maniatis on Prize4Life and ALS Research 05/17/12 National
Biogen Idec Buys Drug Rights from Neurimmune for $32.5M 12/21/10 Boston
Life Wants Ion Torrent for Fast Gene Sequencing, Biogen-Idec Takes On Lou Gehrig’s Disease, Two Biotechs Move Toward IPOs, & More San Diego Life Science News 08/19/10 San Diego
Biogen Idec Strikes Potential $345M Deal with Knopp to Develop ALS Drug 08/18/10 Boston
PatientsLikeMe Growing as Pharma Customers Boost Focus on Patients 02/10/10 Boston
San Diego Inventor’s Drug Discovery is Nothing to Laugh (or Cry) About 09/04/09 San Diego
Isis Prepares Novel Treatment for Lou Gehrig’s Disease, BrainCells Is Encouraged by New Drug for Depression, Inovio Raises $30M, & More San Diego Life Sciences News 08/06/09 San Diego
Isis, Genzyme Use Antisense to Go Where Many Drugs Fail—The Brain 08/05/09 San Diego
No More Tears: Avanir Investors Await Trial Results on Emotional Outburst Drug 07/23/09 San Diego
Link Medicine Raises $40 Million to Counter Neurodegenerative Disease 09/30/08 Boston
Page 1 of 1